The preventive effect on respiratory tract infections of Oscillococcinum(®). A cost-effectiveness analysis

BACKGROUND: Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum(®)) is used to treat and prevent seasonal colds and airway inflammatory affections, improve symptom control, and reduce the frequency of respiratory tract infection (RTI) episodes. The objective of this controlled observati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clinicoecon Outcomes Res
Glavni autori: Colombo, Giorgio L, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Bruno, Giacomo M, Beghi, Gianfranco M
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788925/
https://ncbi.nlm.nih.gov/pubmed/29416364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S144300
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items